patient selection for regorafenib in crc
Published 6 years ago • 343 plays • Length 6:33Download video MP4
Download video MP3
Similar videos
-
5:32
colorectal cancer: regorafenib patient selection and dosing
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
5:31
practical advice for using regorafenib
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
4:08
patient selection for aflibercept in advanced crc
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
3:53
regorafenib in colorectal cancer: optimizing the dose
-
2:07
doctors in shanghai boost chances of organ preservation for rectal cancer patients
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
4:14
the use of regorafenib in clinical practice
-
11:24
managing toxicities associated with regorafenib
-
9:34
regorafenib in colorectal cancer
-
2:13
dr. lenz on the benefit of regorafenib in crc
-
5:53
redos trial: optimizing regorafenib dosing in metastatic colorectal cancer
-
1:20
dr. fukuoka on dosage for regorafenib/nivolumab combo in gastric cancer and crc
-
0:57
dr. bekaii-saab discusses the next steps with regorafenib in crc
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
7:35
use of regorafenib in refractory mcrc
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc